The Gene Polymorphism of Angiotensin-Converting Enzyme Intron Deletion and Angiotensin-Converting Enzyme G2350A in Patients With Left Ventricular Hypertrophy: A Meta-analysis

This publication has 48 references indexed in Scilit:

• Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides
  Scientific Reports, 2012
• Influences of the G2350A polymorphism in the ACE Gene on cardiac structure and function of ball game players
  Journal of Negative Results in BioMedicine, 2012
• New Take on the Role of Angiotensin II in Cardiac Hypertrophy and Fibrosis
  Hypertension, 2011
• Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
  European Journal of Epidemiology, 2010
• Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies
  American Journal of Epidemiology, 2009
• Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes
  Diabetes Care, 2008
• Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
  Proceedings of the National Academy of Sciences, 2006
• From Left Ventricular Hypertrophy to Congestive Heart Failure: Management of Hypertensive Heart Disease
  Progress in Cardiovascular Diseases, 2006
• Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension
  The American Journal of Cardiology, 1996
• Association between a Deletion Polymorphism of the Angiotensin-Converting-Enzyme Gene and Left Ventricular Hypertrophy
  New England Journal of Medicine, 1994